GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » Research & Development

Hunan Fangsheng Pharmaceutical Co (SHSE:603998) Research & Development : ¥145 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hunan Fangsheng Pharmaceutical Co's Research & Development for the three months ended in Mar. 2025 was ¥32 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ¥145 Mil.


Hunan Fangsheng Pharmaceutical Co Research & Development Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co Research & Development Chart

Hunan Fangsheng Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.62 51.40 70.40 107.93 139.21

Hunan Fangsheng Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.97 35.39 42.04 35.83 31.88

Hunan Fangsheng Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥145 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Fangsheng Pharmaceutical Co  (SHSE:603998) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Hunan Fangsheng Pharmaceutical Co Research & Development Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Fangsheng Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN
Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.
Executives
He Shi senior management
Xiao Han Qing senior management
Liu Xin He senior management
Chen Bo Director
Chen Ai Chun Director
Li Zhi Heng senior management
Zhou Wei En senior management
Zhang Qing Hua Director
Huang Min Director
Zhou Xiao Li senior management
Fang Jin Cheng Director
Fang Chuan Long Supervisors
Tan Yuan Ming Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines